These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6363537

  • 1. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.
    Iwata M, Huff TF, Ishizaka K.
    J Immunol; 1984 Mar; 132(3):1286-93. PubMed ID: 6363537
    [Abstract] [Full Text] [Related]

  • 2. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
    Iwata M, Akasaki M, Ishizaka K.
    J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the biologic activities of IgE-binding factors. III. Switching of a T cell hybrid clone from the formation of IgE-suppressive factor to the formation of IgE-potentiating factor.
    Huff TF, Uede T, Iwata M, Ishizaka K.
    J Immunol; 1983 Sep; 131(3):1090-5. PubMed ID: 6224847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
    Iwata M, Ishizaka K.
    J Immunol; 1988 Nov 15; 141(10):3270-7. PubMed ID: 2460527
    [Abstract] [Full Text] [Related]

  • 7. Formation of IgE-binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen-primed spleen cells.
    Uede T, Ishizaka K.
    J Immunol; 1982 Oct 15; 129(4):1391-7. PubMed ID: 6980933
    [Abstract] [Full Text] [Related]

  • 8. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor.
    Uede T, Ishizaka K.
    J Immunol; 1984 Jul 15; 133(1):359-67. PubMed ID: 6609987
    [Abstract] [Full Text] [Related]

  • 9. Regulatory effects of human IgE-binding factors on the IgE response of rat lymphocytes.
    Huff TF, Jardieu P, Ishizaka K.
    J Immunol; 1986 Feb 01; 136(3):955-62. PubMed ID: 3079805
    [Abstract] [Full Text] [Related]

  • 10. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P, Uede T, Ishizaka K.
    J Immunol; 1985 Aug 01; 135(2):922-9. PubMed ID: 2409160
    [Abstract] [Full Text] [Related]

  • 11. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P, Uede T, Ishizaka K.
    J Immunol; 1984 Dec 01; 133(6):3266-73. PubMed ID: 6208275
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme.
    Iwata M, Munoz JJ, Ishizaka K.
    J Immunol; 1983 Oct 01; 131(4):1954-60. PubMed ID: 6555215
    [Abstract] [Full Text] [Related]

  • 13. Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation.
    Uede T, Huff TF, Ishizaka K.
    J Immunol; 1982 Oct 01; 129(4):1384-90. PubMed ID: 6980932
    [Abstract] [Full Text] [Related]

  • 14. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
    Iwata M, Adachi M, Ishizaka K.
    J Immunol; 1988 Apr 15; 140(8):2534-42. PubMed ID: 3258613
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin.
    Uede T, Hirata F, Hirashima M, Ishizaka K.
    J Immunol; 1983 Feb 15; 130(2):878-84. PubMed ID: 6600257
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of the antibody response by antigen-specific glycosylation-enhancing factor.
    Iwata M, Fukutomi Y, Hashimoto T, Sato Y, Sato H, Ishizaka K.
    J Immunol; 1987 Apr 15; 138(8):2561-7. PubMed ID: 3494077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor.
    Ohno H, Iwata M, Katamura K, Ishizaka K.
    Int Immunol; 1990 Apr 15; 2(3):257-66. PubMed ID: 2128469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.